These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11210707)

  • 1. [Driving ability after reversal of phenylephrine 10% induced mydriasis by dapiprazole 0.5%; a prospective study on 65 eyes].
    Schmidbauer JM; Georg T; Möller MR; Ruprecht KW
    Klin Monbl Augenheilkd; 2000 Dec; 217(6):340-4. PubMed ID: 11210707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical use of mydriasis with 10% phenylephrine and its antagonism by 0.5% dapiprazole].
    Schimidbauer JM; Höh H; Franke G; Petsch E; Siegmund W
    Ophthalmologe; 1999 Mar; 96(3):182-6. PubMed ID: 10234966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of mydriasis by dapiprazole.
    Allinson RW; Gerber DS; Bieber S; Hodes BL
    Ann Ophthalmol; 1990 Apr; 22(4):131-3, 138. PubMed ID: 1972008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dapiprazol antagonizes tropicamide- and phenylephrine-induced mydriasis in the elderly].
    Warlich M; Weik R; Höh H; Ruprecht KW
    Ophthalmologe; 1995 Apr; 92(2):179-81. PubMed ID: 7780277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dapiprazole on the reversal of pharmacologically induced mydriasis.
    Nyman N; Keates EU
    Optom Vis Sci; 1990 Sep; 67(9):705-9. PubMed ID: 1978275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical efficacy of Rev-Eyes in reversing the effects of pupillary dilation.
    Connor CG; Campbell JB; Tirey WW
    J Am Optom Assoc; 1993 Sep; 64(9):634-6. PubMed ID: 7901259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapiprazole: will it affect the standard of care for pupillary dilation?
    Bartlett JD; Classé JG
    Optom Clin; 1992; 2(4):113-20. PubMed ID: 1363078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical efficacy of paremyd with and without dapiprazole in subjects with light and dark brown irides.
    Anicho UM; Cooper J; Feldman J; Jaanus SD; Dignam K
    Optom Vis Sci; 1999 Feb; 76(2):94-101. PubMed ID: 10082055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driving ability after pupillary dilatation.
    Goel S; Maharajan P; Chua C; Dong B; Butcher M; Bagga P
    Eye (Lond); 2003 Aug; 17(6):735-8. PubMed ID: 12928686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response study of dapiprazole HCl in the reversal of mydriasis induced by 2.5% phenylephrine.
    Hogan TS; McDaniel DD; Bartlett JD; Hart KK; Paggiarino DA
    J Ocul Pharmacol Ther; 1997 Aug; 13(4):297-302. PubMed ID: 9261765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dapiprazole on accommodative amplitude in eyes dilated with 0.5 percent tropicamide.
    Nyman N; Reich L
    J Am Optom Assoc; 1993 Sep; 64(9):625-8. PubMed ID: 7901257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of dapiprazole with hydroxyamphetamine hydrobromide and tropicamide.
    Johnson ME; Molinari JF; Carter J
    J Am Optom Assoc; 1993 Sep; 64(9):629-33. PubMed ID: 7901258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can I drive after those drops, doctor?
    Watts P; O'Duffy D; Riddell C; McCleod S; Watson SL
    Eye (Lond); 1998; 12 ( Pt 6)():963-6. PubMed ID: 10325996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The additive miotic effects of dapiprazole and pilocarpine.
    Geyer O; Loewenstein A; Shalmon B; Neudorfer M; Lazar M
    Graefes Arch Clin Exp Ophthalmol; 1995 Jul; 233(7):448-51. PubMed ID: 7557512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects on pupil size and accommodation of three regimens of topical dapiprazole.
    Wilcox CS; Heiser JF; Crowder AM; Wassom NJ; Katz BB; Dale JL
    Br J Ophthalmol; 1995 Jun; 79(6):544-8. PubMed ID: 7626570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the clinical pharmacokinetics of pilocarpine, moxisylyte (thymoxamine), and dapiprazole in the reversal of diagnostic pupillary dilation.
    Doughty MJ; Lyle WM
    Optom Vis Sci; 1992 May; 69(5):358-68. PubMed ID: 1350669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intraocular dapiprazole in the rabbit eye.
    Bonomi L; Marchini G; Pagello P; Simonazzi A; Durando L; Ciarniello MG
    J Cataract Refract Surg; 1989 Nov; 15(6):681-4. PubMed ID: 2614713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brimonidine versus dapiprazole: Influence on pupil size at various illumination levels.
    Marx-Gross S; Krummenauer F; Dick HB; Pfeiffer N
    J Cataract Refract Surg; 2005 Jul; 31(7):1372-6. PubMed ID: 16105609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of dapiprazole.
    Johnson ME; Molinari JF
    Optom Vis Sci; 1993 Oct; 70(10):818-21. PubMed ID: 7902553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aceclidine, brimonidine tartrate, and dapiprazole: comparison of miotic effect and tolerability under different lighting conditions.
    Canovetti A; Nardi M; Figus M; Fogagnolo P; Benelli U
    J Cataract Refract Surg; 2009 Jan; 35(1):42-6. PubMed ID: 19101423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.